Lidexa 38.8 mg/g
Lidexa · CREAM · Oncora Pharma, LLC
Lidexa is a cream containing lidexa at 38.8 mg/g, taken topical. Manufactured by Oncora Pharma, LLC.
Key Facts
- Brand Name
- Lidexa
- Generic Name
- Lidexa
- NDC Code (Product)
85477-330- Manufacturer
- Oncora Pharma, LLC
- Strength
- 38.8 mg/g
- Dosage Form
- CREAM
- Route
- TOPICAL
- Marketing Status
- Drug Class
- Amide Local Anesthetic [EPC]; Antiarrhythmic [EPC]
- Marketing Start
- 02/26/2026
Recall History
No Recall HistoryFull Prescribing Information
Indications & Usage
INDICATIONS AND USAGE Lidexa™ is indicated for topical analgesia as directed by a healthcare provider.
Dosage & Administration
DOSAGE AND ADMINISTRATION For topical use only. Apply to the affected area 3 to 4 times daily or as directed by a healthcare provider.
Warnings
WARNINGS For external use only. Not for ophthalmic use. Avoid contact with eyes. Excessive application may result in increased systemic absorption. Keep out of reach of children.
Contraindications
CONTRAINDICATIONS Lidexa™ is contraindicated in patients with known hypersensitivity to lidocaine or any component of the formulation.
Drug Interactions
Drug Interactions
Adverse Reactions
ADVERSE REACTIONS Localized skin reactions such as redness, irritation, or rash may occur.
Frequently Asked Questions
What is Lidexa used for?
Lidexa contains Lidexa. It is a cream taken topical. Consult your doctor for specific uses.
Is Lidexa a controlled substance?
Lidexa is not classified as a controlled substance by the DEA.
What is the generic name for Lidexa?
The generic name for Lidexa is Lidexa. There are no other listed brand versions of Lidexa.
What is the NDC code for Lidexa 38.8 mg/g?
The NDC (National Drug Code) for Lidexa 38.8 mg/g is 85477-330, listed by Oncora Pharma, LLC.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)